Proteolysis-focusing on chimeras (PROTACs) and molecular glue degraders (MGDs) are essentially the most maturely developed TPD procedures. On this evaluation, we focus on both of those preclinical experiments and medical trials to provide a comprehensive summary of the safety and medical success of PROTACs and MGDs in hematologic malignancies over https://abigailn888nfw8.wikibriefing.com/user